Cochlear (Germany) Performance

OC5 Stock  EUR 119.00  0.64  0.53%   
The firm shows a Beta (market volatility) of 1.11, which signifies a somewhat significant risk relative to the market. Cochlear returns are very sensitive to returns on the market. As the market goes up or down, Cochlear is expected to follow. At this point, Cochlear Limited has a negative expected return of -0.36%. Please make sure to confirm Cochlear's variance, jensen alpha, and the relationship between the standard deviation and information ratio , to decide if Cochlear Limited performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cochlear Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Forward Dividend Yield
0.0217
Payout Ratio
0.8151
Forward Dividend Rate
2.58
Ex Dividend Date
2026-03-19
1
Fully implanted cochlear implant study hits key milestone for hearing loss - Stock Titan
12/18/2025
2
Commodity, healthcare stocks drag Australian shares lower Cochlear loses tune - marketscreener.com
02/12/2026
3
Cochlear Director Karen Penrose Increases Indirect Shareholding via On-Market Purchase - TipRanks
02/19/2026
  

Cochlear Relative Risk vs. Return Landscape

If you would invest  15,100  in Cochlear Limited on November 23, 2025 and sell it today you would lose (3,200) from holding Cochlear Limited or give up 21.19% of portfolio value over 90 days. Cochlear Limited is currently producing negative expected returns and takes up 2.3938% volatility of returns over 90 trading days. Put another way, 21% of traded stocks are less volatile than Cochlear, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Cochlear is expected to under-perform the market. In addition to that, the company is 3.21 times more volatile than its market benchmark. It trades about -0.15 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

Cochlear Target Price Odds to finish over Current Price

The tendency of Cochlear Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 119.00 90 days 119.00 
close to 99
Based on a normal probability distribution, the odds of Cochlear to move above the current price in 90 days from now is close to 99 (This Cochlear Limited probability density function shows the probability of Cochlear Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the stock has the beta coefficient of 1.11 . This indicates Cochlear Limited market returns are reactive to returns on the market. As the market goes up or down, Cochlear is expected to follow. Additionally Cochlear Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Cochlear Price Density   
       Price  

Predictive Modules for Cochlear

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cochlear Limited. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
114.90117.31119.72
Details
Intrinsic
Valuation
LowRealHigh
116.41118.82121.23
Details
Naive
Forecast
LowNextHigh
105.99108.40110.82
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-165.03132.33429.69
Details

Cochlear Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cochlear is not an exception. The market had few large corrections towards the Cochlear's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cochlear Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cochlear within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.45
β
Beta against Dow Jones1.11
σ
Overall volatility
10.03
Ir
Information ratio -0.19

Cochlear Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cochlear for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cochlear Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cochlear Limited generated a negative expected return over the last 90 days
About 56.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Cochlear Director Karen Penrose Increases Indirect Shareholding via On-Market Purchase - TipRanks

Cochlear Fundamentals Growth

Cochlear Stock prices reflect investors' perceptions of the future prospects and financial health of Cochlear, and Cochlear fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cochlear Stock performance.

About Cochlear Performance

By analyzing Cochlear's fundamental ratios, stakeholders can gain valuable insights into Cochlear's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cochlear has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cochlear has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia. COCHLEAR LTD operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3500 people.

Things to note about Cochlear Limited performance evaluation

Checking the ongoing alerts about Cochlear for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cochlear Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cochlear Limited generated a negative expected return over the last 90 days
About 56.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Cochlear Director Karen Penrose Increases Indirect Shareholding via On-Market Purchase - TipRanks
Evaluating Cochlear's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cochlear's stock performance include:
  • Analyzing Cochlear's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cochlear's stock is overvalued or undervalued compared to its peers.
  • Examining Cochlear's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cochlear's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cochlear's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cochlear's stock. These opinions can provide insight into Cochlear's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cochlear's stock performance is not an exact science, and many factors can impact Cochlear's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Cochlear Stock analysis

When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios